Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands

被引:24
|
作者
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Radiol, PET Ctr, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[3] Univ N Texas, Ctr Hlth Sci, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
关键词
D O I
10.1021/jm0100077
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of naphthamides were synthesized, and the affinities of these compounds were determined for dopamine D-2 and D-3 receptors using radioligand binding techniques. The naphthamide compounds that were prepared include N-(1-alkylpiperidin-4-yl)-4-bromo-1-methoxy-2-naphthamides (1-6), (S)-N-(1-alkylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamides (7-12), (R)-N-(1-alkylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamides (13-18), (S)-N-(1-alkyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamides (19 -25), (R)-N-(1-alkyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamides (26-31), and N-(9-alkyl-9-azabicyclo-[3.3.1]nonan-3 beta -yl)-4- bromo-1-methoxy-2-naphthamides (32, 33). The results of in vitro radioligand binding studies indicated that the majority of the naphthamide analogues bound with high affinity at both the D-2 and D-3 dopamine receptor subtypes and most of the compounds demonstrated some selectivity for the dopamine D-3 dopamine receptor subtype. These results demonstrated that both the structure of the central amine moiety (piperidine, pyrrolidine, and 9-azabicyclo[3.3.1]nonane) ring and the N-(alkyl) substitution on the amine significantly effects the binding affinity at D-2 and D-3 dopamine receptors. The bulkiness of the N-(1-alkyl) substituent was found to (a) have no effect on pharmacologic selectivity, (b) increase the affinity at Ds receptors, or (c) decrease the affinity at D-2 receptors. The most potent analogue in this series was (S)-N-(1-cycloheptylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamide (10), which had equilibrium dissociation (K-i) values of 1.8 and 0.2 nM for D-2 and D-3 receptors, respectively. The most selective analogue was (R)-N-(1-cycloheptyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamide (30), which had K-i values of 62.8 and 2.4 nM for D-2 and D-3 receptors, respectively. Radioligand binding results for sigma receptors indicated that the structure of the amine moiety and the N-(l-alkyl) substitutions also significantly influence the affinity and selectivity of these compounds at the sigma (1) and sigma (2) sigma receptor subtypes. The two naphthamides containing a 9-azabicyclo[3.3.1]nonan-3 beta -yl central ring were found to be selective for sigma (2) receptors.
引用
收藏
页码:1815 / 1826
页数:12
相关论文
共 50 条
  • [1] The structural evolution of dopamine D3 receptor ligands:: Structure-activity relationships and selected neuropharmacological aspects
    Boeckler, Frank
    Gmeiner, Peter
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 112 (01) : 281 - 333
  • [2] Structure-Activity Relationships of a Negative Allosteric Modulator of the D3 Dopamine Receptor and Investigation of its Binding Site
    Moritz, Amy E.
    Madaras, Nora S.
    Inbody, Laura R.
    Kelley, Amber M.
    Gandhi, Disha M.
    Akano, Emmanuel
    Lee, Kuo H.
    Free, R. B.
    Hu, Xin
    Southall, Noel T.
    Ferrer, Mare
    Shi, Lei
    Frankowski, Kevin J.
    Sibley, David R.
    [J]. FASEB JOURNAL, 2022, 36
  • [3] Structure-Activity Relationships of a Negative Allosteric Modulator of the D3 Dopamine Receptor and Investigation of its Binding Site
    Moritz, Amy
    Inbody, Laura
    Gandhi, Disha
    Akano, Emmanuel
    Fearce, Chelesa
    Free, R.
    Barnaevya, Elena
    Hu, Xin
    Southall, Noel
    Ferrer, Marc
    Keck, Thomas
    Frankowski, Kevin
    Sibley, David
    [J]. FASEB JOURNAL, 2020, 34
  • [4] Synthesis and structure-activity relationships of a series of sigma receptor ligands
    Nahas, Roger
    Lever, John R.
    Lever, Susan Z.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 734 - 734
  • [5] Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
    Shaik, Anver Basha
    Boateng, Comfort A.
    Battiti, Francisco O.
    Bonifazi, Alessandro
    Cao, Jianjing
    Chen, Li
    Chitsazi, Rezvan
    Ravi, Saiprasad
    Lee, Kuo Hao
    Shi, Lei
    Newman, Amy Hauck
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15313 - 15333
  • [6] Synthesis and structure-activity relationships of potent retinoid X receptor ligands
    Farmer, LJ
    Jeong, S
    Kallel, EA
    Koch, SSC
    Croston, GE
    Flatten, KS
    Heyman, RA
    Nadzan, AM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (18) : 2393 - 2398
  • [7] SYNTHESIS AND RADIOIODINATION OF SELECTIVE LIGANDS FOR THE DOPAMINE D3 RECEPTOR SUBTYPE
    Hocke, C.
    Lober, S.
    Hubner, H.
    Gmeiner, P.
    Kuwert, T.
    Prante, O.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S93 - S93
  • [8] Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands
    Jean, Mickael
    Renault, Jacques
    Levoin, Nicolas
    Danvy, Denis
    Calmels, Thierry
    Berrebi-Bertrand, Isabelle
    Robert, Philippe
    Schwartz, J. C.
    Lecomte, J. M.
    Uriac, Philippe
    Capet, Marc
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5376 - 5379
  • [9] Synthesis and radioiodination of selective ligands for the dopamine D3 receptor subtype
    Hocke, C
    Prante, O
    Löber, S
    Hübner, H
    Gmeiner, P
    Kuwert, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 3963 - 3966
  • [10] Structure-function relationships at human D3 dopamine receptor
    Sartania, N
    Strange, PG
    [J]. FASEB JOURNAL, 1997, 11 (09): : A919 - A919